这是描述信息
Search
Submit
Cancel
Nanjing RegeneCore Biotech Co.,Ltd
Nanjing RegeneCore Biotech Co.,Ltd

REGENECORE is an innovative start-up company under the YOUNGY Group, advocating science and culture, paying attention to the growth of employees and enterprises, and maintaining human health.

Nanjing RegeneCore Biotech Co.,Ltd
Nanjing RegeneCore Biotech Co.,Ltd

Mature and complete nanobody humanization technology platform, antibody immunogenicity detection technology platform, and high-throughput nanobody screening technology platform.

这是描述信息

Nanjing RegeneCore Biotech Co.,Ltd

Nanjing RegeneCore Biotech Co.,Ltd is established in the Biomedical Valley of National Nanjing Jiangbei New Area, with a research and office base of nearly 4000 square meters. It is one of the first research and development institutions in the field of nanobodies in China. The company's international scientific consulting expert team has rich experience in the research and development of cell therapy products and clinical applications, providing strong guarantees for the precise positioning and success rate of research and development products. The company has mature and leading nanobody screening technology, and conducts in-depth development in multiple application fields based on this technology.

more
company

NEWS

Nanjing Regenecore has been awarded the qualification for project application by the Ministry of Science and Technology

Nanjing Regenecore has been awarded the qualification for project application by the Ministry of Science and Technology

On June 12th, Nanjing Regenecore Biotech Co.,Ltd completed the registration of the National Science and Technology Management Information System Public Service Platform, opening up a new channel for the company to apply for and undertake national key research and development projects, as well as industry university research cooperation projects. Regenecore will actively allocate resources in new dimensions, cooperate with various domestic and foreign scientific research institutions, universities, enterprises, and scientists, jointly undertake national tasks, and contribute to the rapid and high-quality development of China's biotechnology industry.
Xinhua Daily published an exclusive interview with Regenecore

Xinhua Daily published an exclusive interview with Regenecore

On May 23rd, the Important News section of Xinhua Daily published an exclusive interview with Regenecore, showcasing the "present continuous tense" of the new generation of antibody drugs moving from laboratories to production lines.
Regenecore Holds Spring Day Team Building Activities

Regenecore Holds Spring Day Team Building Activities

On April 26th, all employees of Nanjing Regenecore went to the Laoshan National Forest Park to carry out team building activities and strengthen teamwork among employees.

 

Platforms

High throughput nanobody screening technology platform, nanobody humanization technology platform, antibody immunogenicity detection technology platform, biomacromolecule analysis technology platform, antibody drug CMC process development technology platform

TEL:

025-58608860

Address: Room 07 Building 16 Treehouse, No. 73, Tanmi Road, Jiangbei New District, Nanjing

Enterprise email:rjk@regenecore.com

 

这是描述信息

WeChat cooperative consultation

www.300.cn   nanjing   备案号:ICP18030131-1

please try again.